N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143076 |
| CAS No | NA |
| Mol.F. | C22H23ClN8O |
| Mol.Wt. | 450.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143077 |
| CAS No | NA |
| Mol.F. | C26H30ClN7O2 |
| Mol.Wt. | 508.02 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143078 |
| CAS No | NA |
| Mol.F. | C23H24ClN7O2 |
| Mol.Wt. | 465.94 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143079 |
| CAS No | NA |
| Mol.F. | C22H21ClN10O |
| Mol.Wt. | 476.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143080 |
| CAS No | NA |
| Mol.F. | C22H21ClN6O2 |
| Mol.Wt. | 465.90 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143081 |
| CAS No | NA |
| Mol.F. | C24H23N5O6S |
| Mol.Wt. | 509.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143082 |
| CAS No | NA |
| Mol.F. | C24H21N5O6S |
| Mol.Wt. | 507.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143083 |
| CAS No | NA |
| Mol.F. | C31H29N5O7S |
| Mol.Wt. | 615.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143084 |
| CAS No | NA |
| Mol.F. | C24H25N5O5S |
| Mol.Wt. | 495.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143085 |
| CAS No | NA |
| Mol.F. | C23H21N5O6S |
| Mol.Wt. | 495.51 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143086 |
| CAS No | NA |
| Mol.F. | C14H11N3O6 |
| Mol.Wt. | 317.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143087 |
| CAS No | NA |
| Mol.F. | C9H8N2O5 |
| Mol.Wt. | 224.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143088 |
| CAS No | NA |
| Mol.F. | C11H12N2O5 |
| Mol.Wt. | 252.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143089 |
| CAS No | NA |
| Mol.F. | C8H6N2O5 |
| Mol.Wt. | 210.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143090 |
| CAS No | NA |
| Mol.F. | C10H10N2O5 |
| Mol.Wt. | 238.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143091 |
| CAS No | NA |
| Mol.F. | C13H16N2O9 |
| Mol.Wt. | 344.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |